Cargando…

Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma

Recent advances in immunotherapy have included inhibition of immune checkpoint proteins in the tumor microenvironment and tumor lysate-based vaccination strategies. We combined these approaches in pet dogs with high-grade glioma. Administration of a synthetic peptide targeting the immune checkpoint...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olin, Michael R., Ampudia-Mesias, Elisabet, Pennell, Christopher A., Sarver, Aaron, Chen, Clark C., Moertel, Christopher L., Hunt, Matthew A., Pluhar, G. Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406711/ https://www.ncbi.nlm.nih.gov/pubmed/30682795 http://dx.doi.org/10.3390/cancers11020137

Ejemplares similares

Use of CD200 blockade inhibitor to enhance glioma immunotherapy
por: Mesias, Elisabet, et al.
Publicado: (2015)

TRLS-09. USE OF A PAN-PEPTIDE CHECKPOINT INHIBITOR IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM TUMORS
por: Moertel, Christopher, et al.
Publicado: (2023)

IMMU-10. USE OF A SINGLE PEPTIDE CHECKPOINT INHIBITOR FOR TREATMENT OF CENTRAL NERVOUS SYSTEM TUMORS
por: Moertel, Christopher, et al.
Publicado: (2021)

Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas
por: Ogino, Hirokazu, et al.
Publicado: (2022)

CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy
por: Moertel, Christopher L, et al.
Publicado: (2014)

Understanding and overcoming the immunosuppressive effects of glioma induced immunosuppression
por: Moertel, Christopher, et al.
Publicado: (2013)

Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600–Mutant Low-Grade Glioma
por: Bouffet, Eric, et al.
Publicado: (2023)

MYO5A::FGFR1 represents a novel fusion event in pediatric low-grade glioma
por: Galvin, Robert T, et al.
Publicado: (2023)

Additive Value of Dynamic FDOPA PET/CT for Glioma Grading
por: Girard, Antoine, et al.
Publicado: (2021)

MicroRNA-200b expression level is negatively associated with pathological grading in human gliomas
por: Kong, Xiangyi, et al.
Publicado: (2018)

SRPX Emerges as a Potential Tumor Marker in the Extracellular Vesicles of Glioblastoma
por: Ampudia-Mesias, Elisabet, et al.
Publicado: (2022)

Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives
por: Persico, Pasquale, et al.
Publicado: (2021)

Blastomyces dermatitidis Yeast Lysate Antigen Combinations: Antibody Detection in Dogs with Blastomycosis
por: Boyd, Alex R., et al.
Publicado: (2013)

Measurement of Redox Biomarkers in the Whole Blood and Red Blood Cell Lysates of Dogs
por: González-Arostegui, Luis G., et al.
Publicado: (2022)

The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II
por: Smits, Anja, et al.
Publicado: (2011)

[(18)F]Fluciclovine PET discrimination between high- and low-grade gliomas
por: Parent, Ephraim E., et al.
Publicado: (2018)

(11)C-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence
por: Bag, Asim K., et al.
Publicado: (2022)

Identification of Myeloid Derived Suppressor Cells in Dogs with Naturally Occurring Cancer
por: Goulart, Michelle R., et al.
Publicado: (2012)

Glial Progenitor-Like Phenotype in Low-Grade Glioma and Enhanced CD133-Expression and Neuronal Lineage Differentiation Potential in High-Grade Glioma
por: Rebetz, Johan, et al.
Publicado: (2008)

[(18)F]-fluoro-l-thymidine PET and advanced MRI for preoperative grading of gliomas
por: Collet, S., et al.
Publicado: (2015)

A Comparison of PET Tracers in Recurrent High-Grade Gliomas: A Systematic Review
por: Muthukumar, Sankar, et al.
Publicado: (2022)

Blastomyces dermatitidis: Antibody Detection in Sera from Dogs with Blastomycosis with Yeast Lysate Antigens Produced from Human and Dog Isolates
por: Mondada, Katie, et al.
Publicado: (2014)

The use of lumbar epidural injection of platelet lysate for treatment of radicular pain
por: Centeno, Christopher, et al.
Publicado: (2017)

A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma
por: Xiao, Youchao, et al.
Publicado: (2020)

Novel immune checkpoint-related gene model to predict prognosis and treatment responsiveness in low-grade gliomas
por: Guo, Yangyang, et al.
Publicado: (2023)

Diagnostic and grading accuracy of (18)F-FDOPA PET and PET/CT in patients with gliomas: a systematic review and meta-analysis
por: Xiao, Jiarui, et al.
Publicado: (2019)

The miR-200 family: multiple effects on gliomas
por: Peng, Lilei, et al.
Publicado: (2018)

Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma
por: Petersen, Christopher T., et al.
Publicado: (2019)

Utility of FET-PET in detecting high-grade gliomas presenting with equivocal MR imaging features
por: Puranik, Ameya D., et al.
Publicado: (2019)

Preoperative [(11)C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas
por: Ninatti, Gaia, et al.
Publicado: (2022)

DeLTa-Seq: direct-lysate targeted RNA-Seq from crude tissue lysate
por: Kashima, Makoto, et al.
Publicado: (2022)

A Hybrid Glioma Tumor Cell Lysate Immunotherapy Vaccine Demonstrates Good Clinical Efficacy in the Rat Model
por: Li, Xin-Long, et al.
Publicado: (2020)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

LGG-49. SAFETY AND EFFICACY OF TRAMETINIB (T) MONOTHERAPY AND DABRAFENIB + TRAMETINIB (D+T) COMBINATION THERAPY IN PEDIATRIC PATIENTS WITH BRAF V600-MUTANT LOW-GRADE GLIOMA (LGG)
por: Bouffet, Eric, et al.
Publicado: (2020)

A Potential New Treatment for High-Grade Glioma: A Study Assessing Repurposed Drug Combinations against Patient-Derived High-Grade Glioma Cells
por: Lastakchi, Sarah, et al.
Publicado: (2022)

(11)C–acetate PET/CT: a potential alternative of transcranial biopsy for grading cerebral gliomas
por: Hatazawa, Jun
Publicado: (2018)

NI-10 T2/FLAIR mismatch sign and methionine PET uptake in grade II and III gliomas
por: Ebiko, Yusuke, et al.
Publicado: (2020)

A dataset of [(68)Ga]Ga-Pentixafor PET/CT images of patients with high-grade Glioma
por: Roustaei, Hessamoddin, et al.
Publicado: (2023)

Targeting immune checkpoints in malignant glioma
por: Zhang, Xuhao, et al.
Publicado: (2016)

90K predicts the prognosis of glioma patients and enhances tumor lysate-pulsed DC vaccine for immunotherapy of GBM in vitro
por: Zeng, Yu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a3cgqajtobvm6d6m1s5rpro5kb